Valneva SE VALN
NASDAQ VALN
$6.95 -0.11 (-1.63%)
As of: Sep 4, 2026 · 3:58 PM EDT

Valneva SE (VALN) Payables (2020 - 2026)

Valneva SE (VALN) posted Payables of $25.5 million for Q1 2026, down 10.63% sequentially from $28.6 million in Q4 2025, and down 12.81% YoY from $29.3 million in Q1 2025.

Analysis

Valneva SE (VALN) Payables (2020 - 2026) Analysis & Trends

Valneva SE has reported Payables for 7 years, with the latest figure at $25.5 million in Q1 2026.

  • Quarterly Payables fell 12.81% year-over-year to $25.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.5 million (down 12.81% YoY) and the FY2025 annual result came in at $28.6 million, down 25.7% from the prior year.
  • Payables eased to $25.5 million in Q1 2026 per VALN's latest filing, from $28.6 million in the prior quarter.
  • Over five years, Payables peaked at $102.6 million in Q3 2023 and troughed at $23.9 million in Q2 2025.
  • A 5-year average of $53.4 million and a median of $47.1 million in 2024 frame the typical range for Payables.
  • The sharpest annual moves came in 2023 and 2024: Payables gained 16.33% in 2023, then plunged 54.08% in 2024.
  • Over 5 years, Payables stood at $54.1 million in 2022, then fell by 11.96% to $47.7 million in 2023, then fell by 20.37% to $38.0 million in 2024, then slipped by 24.75% to $28.6 million in 2025, then fell by 10.63% to $25.5 million in 2026.
  • According to Business Quant data, Payables over the past three periods registered $25.5 million, $28.6 million, and $35.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 429.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.16 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.52 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 167.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 88.42 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 470.30 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 108.02 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 35.57 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 428.93 Mn
10 Valneva SE 578.54 Mn 437.28 Mn 1.86 Mn 26.63 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 26.63 Mn
Mar 31, 2026 25.53 Mn
Dec 31, 2025 28.57 Mn
Sep 30, 2025 35.21 Mn
Jun 30, 2025 23.90 Mn
Mar 31, 2025 29.28 Mn
Dec 31, 2024 37.96 Mn
Sep 30, 2024 47.11 Mn
Jun 30, 2024 35.16 Mn
Mar 31, 2024 36.40 Mn
Dec 31, 2023 47.67 Mn
Sep 30, 2023 102.59 Mn
Jun 30, 2023 75.30 Mn
Mar 31, 2023 51.17 Mn
Dec 31, 2022 54.15 Mn
Sep 30, 2022 88.19 Mn
Jun 30, 2022 101.63 Mn
Mar 31, 2022 87.54 Mn
Dec 31, 2021 86.06 Mn
Dec 31, 2020 51.51 Mn